SuperworthiBio shares outstanding IBIO
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 145.5M
- On a year earlier
- +910.2%
- more shares
iBio had 145.5M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 910.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 145.5M | +910% |
| FY2025 | 14.4M | +67% |
| FY2024 | 8.6M | +903% |
| FY2023 | 859K | +97% |
| FY2022 | 436.4K | +1% |
| FY2021 | 434.2K | +96% |
| FY2020 | 220.9K | +455% |
| FY2019 | 39.8K | +69% |
| FY2018 | 23.6K | +32% |
| FY2017 | 17.8K | +1% |
| FY2016 | 17.6K | +16% |
| FY2015 | 15.3K | +16% |
| FY2014 | 13.1K | +21% |
| FY2013 | 10.8K | +13% |
| FY2012 | 9.6K | +48% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 145.5M | +910% | |
| Q3 FY26 | 119.6M | +1113% | |
| Q2 FY26 | 99.1M | +986% | |
| Q1 FY26 | 53M | +514% | |
| Q4 FY25 | 14.4M | +67% | |
| Q3 FY25 | 9.9M | +166% | |
| Q2 FY25 | 9.1M | +392% | |
| Q1 FY25 | 8.6M | +621% | |
| Q4 FY24 | 8.6M | +903% | |
| Q3 FY24 | 3.7M | +463% | |
| Q2 FY24 | 1.9M | +279% | |
| Q1 FY24 | 1.2M | +171% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on iBio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.